<DOC>
	<DOC>NCT01234727</DOC>
	<brief_summary>A Multicentre study comparing 5 different Self-Monitoring Of Blood Glucose (SMBG) system commercially available in Germany &amp; Holland.</brief_summary>
	<brief_title>Comparison Study of Blood Glucose Monitoring Systems in People With Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Subjects diagnosed with type 1 or type 2 diabetes mellitus Age between 18 and 75 years. Patients with stable blood glucose in judgment of the investigator. Subjects receive intensive insulin therapy (Multiple Daily Injection defined as at least two insulin injections per day) Patients perform blood glucose self measurements on a routine basis Patients must have experience in self measurement blood glucose for at least 6 months. Patients with unstable blood glucose in judgment of the investigator. Patient has been diagnosed with progressive / serious diseases that in judgment of the investigator preclude successful completion of the observational period. Lack of compliance or other justifications that, in the discretion of the investigator, precludes satisfactory participation in the study. Subject without legal capacity. Blood donation within the last 30 days. Known pregnancy. Subject has already participated in the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>diabetes, SMBG, glucose testing systems, accuracy</keyword>
</DOC>